TY  - JOUR 
AU  - Zapata-Pavas, L Estefanía
AU  - Serrano-Macia, Marina
AU  - Merlos Rodrigo, Miguel Ángel
AU  - Barrenechea-Barrenechea, Jon Ander
AU  - Peña-SanFelix, Patricia
AU  - Del Río-Álvarez, Álvaro
AU  - Gil-Pitarch, Clàudia
AU  - Rejano-Gordillo, Claudia M
AU  - Goikoetxea-Usandizaga, Naroa
AU  - González-Recio, Irene
AU  - Michalkova, Hana
AU  - Mercado-Gómez, Maria
AU  - Lachiondo-Ortega, Sofia
AU  - Castañeda, Andrea
AU  - Asensio Martín, Maitane
AU  - Murti, Abhishek
AU  - Lelou, Elise
AU  - Nogueiras, Rubén
AU  - Mayor, Ugo
AU  - Heger, Zbynek
AU  - Sancho-Bru, Pau
AU  - Delgado, Teresa C
AU  - Calvisi, Diego F
AU  - Xirodimas, Dimitris P
AU  - Wang, Bruce
AU  - Marin, Jose J G
AU  - Fernandez-Barrena, Maite G
AU  - Armengol, Carolina
AU  - Ávila, Matías
AU  - Martínez-Chantar, María Luz
PY  - 2025
SN  - 0270-9139
UR  - http://hdl.handle.net/10366/170066
AB  - [EN]Hepatoblastoma (HB) is the most common malignant liver tumor in children. Despite advances in multimodal treatment, chemoresistance and relapses remain major clinical challenges. NEDDylation, a post-translational modification involving the...
LA  - eng
PB  - Lippincott Williams and Wilkins
KW  - molecular oncology
KW  - Pediatric liver cancer
KW  - Posttranslational regulation
KW  - Therapeutic target
KW  - Ubiquitin-like modification
TI  - NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway
DO  - 10.1097/HEP.0000000000001614
T2  - Hepatology
ER  -